Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects

Journal Title: Jornal de Pediatria - Year 2017, Vol 93, Issue 1

Abstract

Objective Evidence of oxidative stress was reported in individuals with Down syndrome. There is a growing interest in the contribution of the immune system in Down syndrome. The aim of this study is to evaluate the coenzyme Q10 and selected pro-inflammatory markers such as interleukin 6 and tumor necrosis factor α in children with Down syndrome. Methods Eighty-six children (5–8 years of age) were enrolled in this case-control study from two public institutions. At the time of sampling, the patients and controls suffered from no acute or chronic illnesses and received no therapies or supplements. The levels of interleukin 6, tumor necrosis factor α, coenzyme Q10, fasting blood glucose, and intelligence quotient were measured. Results Forty-three young Down syndrome children and forty-three controls were included over a period of eight months (January–August 2014). Compared with the control group, the Down syndrome patients showed significant increase in interleukin 6 and tumor necrosis factor α (p=0.002), while coenzyme Q10 was significantly decreased (p=0.002). Also, body mass index and fasting blood glucose were significantly increased in patients. There was a significantly positive correlation between coenzyme Q10 and intelligence quotient levels, as well as between interleukin 6 and tumor necrosis factor α. Conclusion Interleukin 6 and tumor necrosis factor α levels in young children with Down syndrome may be used as biomarkers reflecting the neurodegenerative process in them. Coenzyme Q10 might have a role as a good supplement in young children with Down syndrome to ameliorate the neurological symptoms.

Authors and Affiliations

Angie M. S. Tosson

Keywords

Related Articles

Which children account for repeated admissions within 1 year in a Brazilian pediatric intensive care unit?

Objective While studies have focused on early readmissions or readmissions during the same hospitalization in a pediatric intensive care unit, little is known about the children with recurrent admissions. We sought to as...

Calcium intake by adolescents: a population-based health survey

Objective To analyze calcium intake in adolescents according to sociodemographic variables, health-related behaviors, morbidities, and body mass index. Methods This was a cross-sectional population-based study, with a t...

Social and biological determinants of growth and development in underprivileged societies

The stimulating study by da Rocha Neves et al. (in this issue)1 addresses the role of social and biological factors in growth and development of young children in a disadvantaged society. The authors assessed a group of...

Erratum on “Association between physical activity, participation in Physical Education classes, and social isolation in adolescents”

In the list of authors of the original article, where it reads Carolina da F.B.F. Santos, it should read Carolina da Franca Bandeira Ferreira Santos. In the sentence “Please cite this article as:” where it reads Santos...

Decreased health-related quality of life in children and adolescents with autoimmune hepatitis

Objective The objective of this study was to evaluate the health-related quality of life in children and adolescents with autoimmune hepatitis. Methods A cross-sectional assessment with the Pediatric Quality of Life Inv...

Download PDF file
  • EP ID EP510518
  • DOI 10.1016/j.jped.2016.04.012
  • Views 70
  • Downloads 0

How To Cite

Angie M. S. Tosson (2017). Coenzyme Q10 and pro-inflammatory markers in children with Down syndrome: clinical and biochemical aspects. Jornal de Pediatria, 93(1), 100-104. https://europub.co.uk./articles/-A-510518